Royalty Pharma (RPRX) Dividend Coverage Ratio Growth (5y) (2024 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Dividend Coverage Ratio Growth (5y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.43 Bn | 131.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.59 Bn | 77.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.44 Bn | 58.26 Bn | 1.37 Bn |
| 4 | Moderna | 57.54 Bn | 52.40 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.97 Bn | 43.97 Bn | - |
| 6 | BeOne Medicines | 40.01 Bn | 34.91 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.18 Bn | 31.87 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.35 Bn | 26.18 Bn | 358.27 Mn |
| 10 | Incyte | 25.55 Bn | 21.02 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.97% |
| Mar 31, 2026 | 56.16% |
| Dec 31, 2025 | 54.65% |
| Sep 30, 2025 | 19.29% |
| Jun 30, 2025 | -13.26% |
| Mar 31, 2025 | 64.21% |
| Dec 31, 2024 | -22.92% |
| Sep 30, 2024 | 18.29% |